Masaya Akashi

Country flagJapan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (4)

Year:

2026

Lung cancer remains one of the deadliest forms of cancer worldwide; thus, there is an urgent need to continually devise new strategies to effectively treat this condition. In this review, we will discuss one of the previously less studied but important aspects of the oral microbiome in both accelerating the development of lung cancer and modulating the efficacy of its treatment modalities. Herein, following an exhaustive search of available databases, we summarize the current knowledge on the association between oral microbiota and lung cancer, focusing on its impact on the efficacy and complications of widely used lung cancer treatments, including surgery, radiotherapy, chemotherapy, and immunotherapy. We also discuss the evidence supporting the use of oral microbiome-targeting interventions in improving outcomes in lung cancer, both preclinically and clinically, and conclude that the full potential of modulating oral dysbiosis in lung cancer has yet to be realized, requiring broader and larger-scale studies in the future. We hope that this review will highlight the importance of an often-forgotten aspect of lung cancer treatment optimization.

Year:

2026

Year:

2025

Objectives Medication‐related osteonecrosis of the jaw (MRONJ) is a severe adverse effect of antiresorptive and/or antiangiogenic agents. As the treatment application for MRONJ is controversial, we aimed to identify the risk factors for poor prognosis and to help determine appropriate management. Methods This study included 119 patients. Relevant clinical data were obtained for all the patients. In computed tomography images, osteosclerosis, osteolysis, cortical perforation (buccal or lingual), periosteal reaction, and sequestration were evaluated. Results Multivariate analyses showed statistically significant associations between poor prognosis in patients with MRONJ and conservative treatment alone (hazard ratio [HR] 1.89), osteolysis (HR 4.67), and the absence of sequestration (HR 5.33). Conclusions Conservative treatment alone without clear objectives needs to be avoided, and osteolytic change could be the criteria for surgical intervention. As the boundary between the lesion and vital bone is indistinct, we recommend extensive surgery in cases with unpredictable sequestration.

Year:

2023

Collaborators (4)

Tatsuya Nagano

Kobe University Graduate School of Medicine

JAPAN
View details

Noriaki Emoto

Professor

Kobe Pharmaceutical University

JAPAN
View details

yasumasa kakei

Kobe University

JAPAN
View details

Manabu Shigeoka

Senior Assistant Professor

Kobe University

JAPAN
View details